Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Forrest

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Pharmacogenomics|February 28, 2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIVQing Ma, Daniel Brazeau, Barry S Zingman, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2017
New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniaeZackery P Bulman, Michael J Satlin, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with CeftolozaneBrian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumanniiBrian T Tsuji, Cornelia B Landersdorfer, Justin R Lenhard, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsPatrick F Smith, Gregory K Robbins, Robert W Shafer, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2018
Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosaYu-Wei Lin, Heidi H Yu, Jinxin Zhao, et al.
The Journal of Antibiotics|December 17, 2015
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumanniiThien B Tran, Soon-Ee Cheah, Heidi H Yu, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategiesGauri G Rao, Neang S Ly, Jürgen B Bulitta, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Pharmacogenomics|February 28, 2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIVQing Ma, Daniel Brazeau, Barry S Zingman, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumoniaSujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy|February 8, 2017
New Polymyxin B Dosing Strategies To Fortify Old Allies in the War against KPC-2-Producing Klebsiella pneumoniaeZackery P Bulman, Michael J Satlin, Liang Chen, et al.
Antimicrobial Agents and Chemotherapy|September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with CeftolozaneBrian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumanniiBrian T Tsuji, Cornelia B Landersdorfer, Justin R Lenhard, et al.
Antimicrobial Agents and Chemotherapy|July 29, 2005
Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitorsPatrick F Smith, Gregory K Robbins, Robert W Shafer, et al.
Antimicrobial Agents and Chemotherapy|April 11, 2018
Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosaYu-Wei Lin, Heidi H Yu, Jinxin Zhao, et al.
The Journal of Antibiotics|December 17, 2015
Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumanniiThien B Tran, Soon-Ee Cheah, Heidi H Yu, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategiesGauri G Rao, Neang S Ly, Jürgen B Bulitta, et al.
Pageof 18